Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Executive Editor - Health, Beauty and Wellness Insight
USA
+16 year(s) experience
HBW Insight
By Ryan Nelson 11 Dec 2019
Farah Ahmed, president and CEO of the Fragrance Creators Association, discusses the trade group’s expansion in recent years beyond immediate regulatory and legislative concerns to a platform for robust member collaboration in the name of positively impacting the world.
HBW Insight
By Ryan Nelson 28 Nov 2019
Industry advocates working to support GRASE determinations for eight UV filters are faced with a dilemma. They would like to share nonpublic studies with the FDA on a confidential basis – at least to get initial temperature readings from the agency as to the studies’ usefulness in addressing data gaps – but under the current OTC monograph framework, no such pathway exists.
HBW Insight
By Ryan Nelson 13 Jun 2019
The Cosmetic Ingredient Review’s newly figured margins of safety for single- and multi-paraben use in cosmetic products are dramatically lower than previous MOSs that informed the Expert Panel’s 2008 “safe as used” conclusions. Whether the panel still deems the MOSs sufficiently protective is the question going into the group’s Sept. 24-25 meeting.
Rose Sheet
By Ryan Nelson 11 Jun 2019
While FDA does not identify specific product types on the agenda for its public workshop on approaches in skin toxicity testing for topical drug products, advocacy and trade groups anticipate sunscreen ingredient testing could be among the discussion topics. Product expansions have been stifled by regulatory concerns, drawing particular attention from the public health community.
Topic FDA
Rose Sheet
By Ryan Nelson 22 Aug 2018
EU sources update Rose Sheet on contentious initiatives to cement the Commission’s pathway for banning carcinogenic, mutagenic or reprotoxic substances in cosmetics and to promote fragrance allergen awareness and risk management.
Topic Policy and regulation
Rose Sheet
By Ryan Nelson 22 Aug 2018
Companies have had two years to prepare for new warning requirements under California’s Prop 65, which go live at the end of August. Attorneys say new warning responsibilities in e-commerce settings are among changes most likely to imperil businesses (and enable bounty hunters).
Topic Business strategies
Rose Sheet
By Ryan Nelson 22 Aug 2018
The agency’s survey of eye-area cosmetics marketed as free of traditional preservatives doesn’t raise any obvious red flags. However, it does point to a possible contamination source and suggests “the limits of preservative activity in cosmetics.”
Topic FDA
Rose Sheet
By Ryan Nelson 17 Aug 2018
Avisco, a biotech startup focused on the antimicrobial properties of the Inula viscosa plant, and IMD Natural Solutions, whose INS Glycolipid mushroom extract purportedly is “up to 80 times more effective than traditional preservatives,” are among winners named Aug. 6 by GC3.
Topic BioPharmaceutical
HBW Insight
21 Feb 2020
HBW Insight
20 Feb 2020
HBW Insight
19 Feb 2020
HBW Insight
18 Feb 2020
HBW Insight
12 Feb 2020
HBW Insight
10 Feb 2020
HBW Insight
07 Feb 2020
HBW Insight
07 Feb 2020
HBW Insight
05 Feb 2020
HBW Insight
04 Feb 2020
HBW Insight
30 Jan 2020
HBW Insight
29 Jan 2020
Pink Sheet
18 Oct 2018
Pink Sheet
15 Aug 2018
Pink Sheet
01 Jun 2017
